Integra LifeSciences Holdings Corp buy melinda
Startpreis
29.08.18
/
50%
53,24 €
Kursziel
06.09.18
55,92 €
Rendite (%)
5,47 %
Endpreis
06.09.18
56,15 €
Zusammenfassung
Diese Einschätzung wurde am 06.09.18 mit einem Endkurs von 56,15 € beendet. Leichte Gewinne von 5,47 % verzeichnete die BUY Einschätzung von melinda. melinda hat 50% Zuversicht bei dieser EinschätzungRendite ohne Dividenden (%)
Name | 1W | 1M | 1J | 3J |
---|---|---|---|---|
Integra LifeSciences Holdings Corp | -14,18 % | -14,18 % | -49,56 % | -62,30 % |
iShares Core DAX® | 4,09 % | 3,54 % | 17,40 % | 20,33 % |
iShares Nasdaq 100 | 1,42 % | 0,51 % | 39,21 % | 55,37 % |
iShares Nikkei 225® | -1,57 % | -4,63 % | 15,73 % | 2,15 % |
iShares S&P 500 | 1,82 % | 0,96 % | 30,40 % | 45,95 % |
Kommentare von melinda zu dieser Einschätzung
In der Diskussion Integra LifeSciences Holdings Corp diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 06/09 | 14:35 Présentation
Develops, manufactures and markets medical devices, implants and biomaterials
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment.
It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments.
The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
The Orthopedics and Tissue Technologies segment comprises offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair.
The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment.
It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments.
The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
The Orthopedics and Tissue Technologies segment comprises offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair.
The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.
Nombre d'employés : 4 400 personnes.
(Zielkurs erreicht)
Beendete Einschätzungen von melinda zu Integra LifeSciences Holdings Corp
Integra LifeSciences Holdings Corp
Startkurs
Kursziel
Rendite (%)
44,40 €
26.10.22
26.10.22
48,00 €
26.10.23
26.10.23
-24,77 %
26.10.23
26.10.23
Integra LifeSciences Holdings Corp
Startkurs
Kursziel
Rendite (%)
45,33 €
28.09.17
28.09.17
49,61 €
05.02.18
05.02.18
5,07 %
05.02.18
05.02.18
Integra LifeSciences Holdings Corp
Startkurs
Kursziel
Rendite (%)
48,26 €
07.07.17
07.07.17
49,16 €
12.07.17
12.07.17
1,87 %
12.07.17
12.07.17